Oral cisapride dosage forms with an extended duration
US6221396A · kind A · utility
5Cited by
10References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 1999 |
| Grant date | Apr 24, 2001 |
| Priority date | — |
| Expiry date | Jul 7, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4468
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides sustained release oral solid dosage forms of cisapride by using a multi-particulate system, which are bioavailable and can provide efficient blood level of cisapride over 24 hours. Unit dosage forms of cisapride which comprise a plurality of substrates containing sustained release cisapride, as well as pharmaceutical compositions containing the dosage forms, are also disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.